A phase II study of the VEGFR inhibitor pazopanib (P) in patients with newly diagnosed or relapsed malignant pleural mesothelioma (MPM): an NCCTG study
- Citation:
- J Thorac Oncol vol 4 (9 suppl 1) PD4.1.2, S456
- Meeting Instance:
- IASLC (WCLC) 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2221
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. R. Molina S. J. Mandrekar K. L. Allen Ziegler G. S. Soori K. M. Rowland Jr S. E. Schild P. Ivy A. A. Adjei
- Networks:
- Study
- NCCTG-N0623
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: